Abstract
The mammalian target of rapamycin, mTOR, regulates cell growth and proliferation. Here we show that the initiation factor of translation (eIF-4E), a downstream effector of mTOR, has oncogenic effects in vivo and cooperates with c-Myc in B-cell lymphomagenesis. We found that c-Myc overrides eIF-4E-induced cellular senescence, whereas eIF-4E antagonizes c-Myc-dependent apoptosis in vivo. Our results implicate activation of eIF-4E as a key event in oncogenic transformation by phosphoinositide-3 kinase and Akt.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Akt: a key transducer in cancer
Journal of Biomedical Science Open Access 01 October 2022
-
Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation
Cancer Cell International Open Access 22 April 2022
-
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Signal Transduction and Targeted Therapy Open Access 30 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Schmelzle, T. & Hall, M.N. Cell 103, 253–262 (2000).
Di Cristofano, A. & Pandolfi, P.P. Cell 100, 387–390 (2000).
Neshat, M.S. et al. Proc. Natl. Acad. Sci. USA 98, 10314–10319 (2001).
Podsypanina, K. et al. Proc. Natl. Acad. Sci. USA 98, 10320–10325 (2001).
Waskiewicz, A.J., Flynn, A., Proud, C.G. & Cooper, J.A. EMBO J. 16, 1909–1920 (1997).
Zimmer, R., DeBenedetti, A. & Graff, J.R. Anticancer Res. 203, 1343–1351 (2000).
Lazaris-Karatzas, A., Montine, K.S. & Sonenberg, N. Nature 345, 544–547 (1990).
Lazaris-Karatzas, A. & Sonenberg, N Mol. Cell. Biol. 12, 1234–1238 (1992).
Seki, N. et al. Clin. Cancer. Res. 8, 3046–3053 (2002).
Wang, S. et al. Am. J. Pathol. 155, 247–255 (1999).
Harris, A.W. et al. Nature 167, 353–371 (1988).
Iritani, B.N. & Eisenman, R.N. Proc. Natl. Acad. Sci. USA 96, 13180–13185 (1999).
Evan, G.I. et al. Cell 69, 119–128 (1992).
Polunovsky, V.A. et al. Mol. Cell. Biol. 16, 6573–6581 (1996).
Dimri, G.P. et al. Proc. Natl. Acad. Sci. USA 92, 9363–9367 (1995).
Acknowledgements
This work was partially supported by the National Cancer Institute and the Irma T. Hirschl/Monique Weill-Caulier Award to P.P.P. We thank L. DiSantis for editing the manuscript and M. Barna, L. Longo and C. Tonini for support and suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Ruggero, D., Montanaro, L., Ma, L. et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10, 484–486 (2004). https://doi.org/10.1038/nm1042
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1042
This article is cited by
-
Akt: a key transducer in cancer
Journal of Biomedical Science (2022)
-
Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation
Cancer Cell International (2022)
-
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Signal Transduction and Targeted Therapy (2021)
-
Cellular senescence and its role in white adipose tissue
International Journal of Obesity (2021)
-
Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML
Leukemia (2021)